Persistent inflammation plays a central role in CKD progression by promoting a profibrotic microenvironment through elevated levels of cytokines, such as tumor necrosis factor-alpha (TNF-α), interleukin-6 (IL-6), and reactive oxygen species (ROS). This evidence concerns the gene IL6 and chronic kidney disease.